Thomas Garner - 09 Oct 2023 Form 4 Insider Report for LEXICON PHARMACEUTICALS, INC. (LXRX)

Role
SVP, Chief Commercial Officer
Signature
/s/ Thomas A. Garner
Issuer symbol
LXRX
Transactions as of
09 Oct 2023
Transactions value $
$0
Form type
4
Filing time
11 Oct 2023, 16:02:24 UTC
Next filing
12 Feb 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LXRX Stock Option (Right to Buy) Award $0 +249K $0.00 249K 09 Oct 2023 Common Stock 249K $1.08 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant (10/9/2024) and vests 1/48th per month for each month of service thereafter.